JP2012525121A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012525121A5 JP2012525121A5 JP2012507624A JP2012507624A JP2012525121A5 JP 2012525121 A5 JP2012525121 A5 JP 2012525121A5 JP 2012507624 A JP2012507624 A JP 2012507624A JP 2012507624 A JP2012507624 A JP 2012507624A JP 2012525121 A5 JP2012525121 A5 JP 2012525121A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- tumor
- associated antigen
- antibody
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical class 0.000 claims 104
- 108020004707 nucleic acids Proteins 0.000 claims 95
- 102000039446 nucleic acids Human genes 0.000 claims 95
- 206010028980 Neoplasm Diseases 0.000 claims 68
- 239000000427 antigen Substances 0.000 claims 50
- 102000036639 antigens Human genes 0.000 claims 50
- 108091007433 antigens Proteins 0.000 claims 50
- 238000000034 method Methods 0.000 claims 20
- 239000003795 chemical substances by application Substances 0.000 claims 15
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 12
- 210000004027 cell Anatomy 0.000 claims 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 9
- 201000011510 cancer Diseases 0.000 claims 9
- 230000000295 complement effect Effects 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 9
- 210000001744 T-lymphocyte Anatomy 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 229920001184 polypeptide Polymers 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 4
- 239000000523 sample Substances 0.000 claims 4
- 230000002159 abnormal effect Effects 0.000 claims 3
- 230000000692 anti-sense effect Effects 0.000 claims 3
- 239000000032 diagnostic agent Substances 0.000 claims 3
- 229940039227 diagnostic agent Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 108020004459 Small interfering RNA Proteins 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 230000001461 cytolytic effect Effects 0.000 claims 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 206010061968 Gastric neoplasm Diseases 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000037841 lung tumor Diseases 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 208000023958 prostate neoplasm Diseases 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 230000001875 tumorinhibitory effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17387109P | 2009-04-29 | 2009-04-29 | |
| EP09005931A EP2249159A1 (en) | 2009-04-29 | 2009-04-29 | Identification of tumor-associated markers for diagnosis and therapy |
| EP09005931.2 | 2009-04-29 | ||
| US61/173,871 | 2009-04-29 | ||
| PCT/EP2010/002490 WO2010124812A2 (en) | 2009-04-29 | 2010-04-22 | Identification of tumor-associated markers for diagnosis and therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012525121A JP2012525121A (ja) | 2012-10-22 |
| JP2012525121A5 true JP2012525121A5 (enExample) | 2013-05-30 |
Family
ID=41100608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507624A Pending JP2012525121A (ja) | 2009-04-29 | 2010-04-22 | 診断および治療のための腫瘍関連マーカーの同定 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120070430A1 (enExample) |
| EP (2) | EP2249159A1 (enExample) |
| JP (1) | JP2012525121A (enExample) |
| AU (1) | AU2010243863A1 (enExample) |
| CA (1) | CA2760395A1 (enExample) |
| WO (1) | WO2010124812A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2562721A (en) * | 2017-05-16 | 2018-11-28 | Fastbase Solutions Ltd | Kits, methods and their uses for detecting cell-cell interactions in a sample |
| WO2023244744A2 (en) * | 2022-06-15 | 2023-12-21 | Nonexomics, Inc. | Compositions and methods for treatment of cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9019812D0 (en) | 1990-09-11 | 1990-10-24 | Scotgen Ltd | Novel antibodies for treatment and prevention of infection in animals and man |
| US5677139A (en) | 1995-04-21 | 1997-10-14 | President And Fellows Of Harvard College | In vitro differentiation of CD34+ progenitor cells into T lymphocytes |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| US20070042392A1 (en) * | 2000-02-03 | 2007-02-22 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
| KR101215789B1 (ko) | 2000-03-30 | 2012-12-26 | 화이트헤드 인스티튜트 포 바이오메디칼 리서치 | Ｒｎａ 간섭의 ｒｎａ 서열 특이적인 매개체 |
| AU2003297318A1 (en) * | 2002-12-20 | 2004-07-22 | Millennium Pharmaceuticals, Inc. | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476. |
| DE102005013846A1 (de) * | 2005-03-24 | 2006-10-05 | Ganymed Pharmaceuticals Ag | Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie |
| US20070231822A1 (en) * | 2006-02-28 | 2007-10-04 | Michael Mitas | Methods for the detection and treatment of cancer |
| US20110236903A1 (en) * | 2008-12-04 | 2011-09-29 | Mcclelland Michael | Materials and methods for determining diagnosis and prognosis of prostate cancer |
-
2009
- 2009-04-29 EP EP09005931A patent/EP2249159A1/en not_active Withdrawn
-
2010
- 2010-04-22 WO PCT/EP2010/002490 patent/WO2010124812A2/en not_active Ceased
- 2010-04-22 EP EP10716294A patent/EP2425252A2/en not_active Withdrawn
- 2010-04-22 CA CA2760395A patent/CA2760395A1/en not_active Abandoned
- 2010-04-22 US US13/266,368 patent/US20120070430A1/en not_active Abandoned
- 2010-04-22 JP JP2012507624A patent/JP2012525121A/ja active Pending
- 2010-04-22 AU AU2010243863A patent/AU2010243863A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12235270B2 (en) | Depleting tumor-specific tregs | |
| JP2007537197A5 (enExample) | ||
| ES2583754T3 (es) | Productos génicos expresados de manera diferencial en tumores y utilización de los mismos | |
| JP2010047597A5 (enExample) | ||
| ES2664386T3 (es) | Identificación de antígenos asociados a tumor para el diagnóstico y la terapia | |
| JP2007506417A5 (enExample) | ||
| JP2008537546A5 (enExample) | ||
| JP2006516190A5 (enExample) | ||
| JP2010063458A5 (enExample) | ||
| CN105349618B (zh) | 三阴性乳腺癌标记物及其在诊断和治疗中的应用 | |
| JP2008508861A5 (enExample) | ||
| CN109790582A (zh) | 基于c-maf状态的乳腺癌治疗性治疗 | |
| JP2009540852A5 (enExample) | ||
| AU2020322440A1 (en) | Compositions and methods of using C/EBP alpha saRNA | |
| DK2984108T3 (en) | Anti-s100a7 antibodies for the treatment and diagnosis of cancer | |
| JP2007526759A5 (enExample) | ||
| CN109709335B (zh) | 热休克蛋白hspa4在肿瘤转移预测、预后评估和治疗中的应用 | |
| JP2012525121A5 (enExample) | ||
| CN106701902B (zh) | Foxr2基因和表达产物在肝癌诊断与治疗中的应用 | |
| CN108003239A (zh) | 一种全人源抗egfr单链抗体及其应用 | |
| JP2009523004A5 (enExample) | ||
| CN110713544A (zh) | 融合基因plekha6-ntrk3及其在lch中的应用 | |
| US9581598B2 (en) | Diagnosis and treatment of brain tumor | |
| WO2014172634A1 (en) | Compositions and methods for inhibiting chemoresistance in cancer and improving response to therapy | |
| CN101161283B (zh) | CMTM1-v17的新应用及其拮抗剂 |